Assessing the impact of extending seasonal malaria chemoprevention from four to five monthly cycles in Burkina Faso

Seasonal malaria chemoprevention (SMC) typically involves administering antimalarial medicines to eligible children over four monthly cycles during periods of high malaria transmission. In 2021, as part of a stratification exercise to inform subnational tailoring of malaria interventions, a fifth monthly SMC cycle was introduced in districts with longer high transmission seasons in Burkina Faso. There is currently no real-world evidence on the impact of adding a fifth monthly cycle. This study assesses the impact of an additional cycle of SMC on malaria incidence and mortality using routine surveillance data.

This poster was presented at the 72nd annual meeting of the American Society of Tropical Medicine and Hygiene.

Click here to download

Country: Burkina Faso